Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

Study of PX-866 and Docetaxel in Solid Tumors

ClinicalTrials.gov ID: NCT01204099

Public ClinicalTrials.gov record NCT01204099. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 9:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 1/2 Study of PX-866 and Docetaxel in Patients With Solid Tumors

Study identification

NCT ID
NCT01204099
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Cascadian Therapeutics Inc.
Industry
Enrollment
223 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2010
Primary completion
Nov 30, 2013
Completion
Jan 31, 2014
Last update posted
May 15, 2018

2010 – 2014

United States locations

U.S. sites
29
U.S. states
15
U.S. cities
26
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
Southwest Cancer Care Escondido California 92025
Bay Area Cancer Research Group, LLC Pleasant Hill California 94523
University of Colorado Cancer Center Aurora Colorado 80045
Eastern Colorado Health Care System - Denver VA Denver Colorado 80220
Cancer Center of Pasco-Pinellas Holiday Florida 34619
Cancer Center of Kansas Wichita Kansas 67214
John Hopkins University Baltimore Maryland 21231
Washington University St Louis Missouri 63110
New Mexico Cancer Care Alliance Albuquerque New Mexico 87131
Roswell Park Cancer Institute Buffalo New York 14263
New York Oncology, Hematology Latham New York 12110
Beth Israel Hospital New York New York 10003
New York University Medical Center New York New York 10016
Columbia University Medical Center New York New York 10032
Montefiore Medical Center The Bronx New York 10467
Northwest Cancer Specialists Tualatin Oregon 97062
University of Pennsylvania Philadelphia Pennsylvania 19104
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232
Medical University of South Carolina Charleston South Carolina 29425
Texas Oncology - South Austin Austin Texas 78745
Mary Crowley Cancer Center Dallas Texas 75201
Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas 75246
Oncology and Hematology Associates of SW Virginia, DBA Blue Ridge Cancer Care Christiansburg Virginia 24073
Virginia Cancer Specialists Fairfax Virginia 22031
Virginia Oncology Associates Newport News Virginia 23606
Columbia Basin Hematology & Oncology Kennewick Washington 99336
Medical Oncology Associates Spokane Washington 99208
Yakima Valley Memorial Hospital/North Star Lodge Yakima Washington 98902

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01204099, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 15, 2018 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01204099 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →